The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Prostate cancer-case controlled study of African-American versus white men, VA versus private sector
Quality of life and patient utility for veterans with prostate cancer
Breast Cancer
Breast cancer among women veterans
Other Cancers
VA marrow transplantation: potential demand, resource use, effectiveness
Posttreatment management options for lung cancer patients
Evaluation of compliance in colorectal tumor postoperative screening
An evaluation of the risk factors for colon cancer and determination of follow-up intervals for screening
Teledermatology: Diagnosing dermatologic lesions by digital imaging
Comprehensive outcomes of nonmelanoma skin cancer
SOURCE: Department of Veterans Affairs, Office of Research and Development, Mary Jones, personal communication to Maria Hewitt, January 7, 1999.
Private Organizations Funding Research
American Cancer Society
The American Cancer Society (ACS) is the largest non-government funder of cancer research in the United States ($93.4 million in 1996) (McGeary, 1999).
Intramural Research Programs
Department of Epidemiology and Surveillance Research. Assessment of the Quality of Treatment Data. The ACS in collaboration with the American College of Surgeons and three state cancer registries (Illinois, Kentucky, Louisiana) is evaluating the completeness and quality of treatment data for patients with colon cancer. Different approaches to collecting data from both hospital and outpatient settings will be assessed with the aim of estimating the proportion of colon cancer patients who receive optimal treatment, given the stage of their disease at diagnosis. Data acquired in a more timely fashion could be used by clinicians, individual hospitals, and state health department officials as benchmarks to gauge the quality of care provided. Success in this feasibility study could lead to the study of other cancer sites in additional states. Funding for this feasibility study is less than $100,000 (P. Wingo, Department of Epidemiology and Surveillance Research, American Cancer Society, personal communication to Maria Hewitt, October 1998).
